Proactively manage your pharmacy inventory
Manage your formulary budget
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||SILVER SULFADIAZINE USED IN THE TREATMENT OF BURNS|
|Abstract:||Silver sulfadiazine has been found to be useful in burn therapy by applying to the affected surface silver sulfadiazine, preferably dispersed in a water-dispersible hydrophilic carrier.|
|Inventor(s):||Fox, Jr.; Charles L. (New York, NY)|
|Assignee:||Research Corporation (New York, NY)|
1. A method of treating burns in man and animal which comprises topically applying an effective anti-bacterial amount of silver sulfadiazine to the affected surface.
2. A method in accordance with claim 1 wherein said silver sulfadiazine is applied as a dispersion in a water-dispersible, hydrophilic carrier.
3. A method in accordance with claim 1 wherein said silver sulfadiazine is applied as a dispersion in a semi-soft or cream-like, water-dispersible or water-soluble oil-in-water emulsion carrier.
4. A method in accordance with claim 1 wherein said silver sulfadiazine is applied as a dispersion in a water-dispersible, hydrophilic carrier, said carrier containing an amount in the range from about 0.1 to about 10 percent by weight of silver sulfadiazine dispersed therein.
5. A method in accordance with claim 1 wherein silver sulfadiazine is applied as a dispersion in a semi-soft or cream-like, water-dispersible or water-soluble oil-in-water emulsion carrier, said carrier containing an amount in the range from about 0.1 to about 10 percent by weight of silver sulfadiazine dispersed therein.
6. A method in accordance with claim 2 wherein said dispersion consists essentially of 0-25 percent by weight petrolatum, 7-45 percent by weight of a long chain fatty alcohol having a carbon atom content in the range C.sub.16 -C.sub.22, 0.1-10 percent by weight silver sulfadiazine, 4-16 percent by weight of a non-ionic emulsifying agent, 7-40 percent by weight of a humectant selected from the group consisting of propylene glycol, sorbitol and glycerin, 0-15 percent by weight of an emollient and an amount of water, when required, sufficient to bring the total of the percentages of the above-identified components to 100 percent.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.